Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis
(1) Background: The endothelial glycocalyx is a primary target during the early phase of sepsis. We previously reported a newly developed recombinant non-fucosylated antithrombin has protective effects in vitro. We further evaluated the effects of this recombinant antithrombin on the glycocalyx dama...
Main Authors: | Toshiaki Iba, Jerrold H. Levy, Koichiro Aihara, Katsuhiko Kadota, Hiroshi Tanaka, Koichi Sato, Isao Nagaoka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/1/176 |
Similar Items
-
The Comparison of the Protective Effects of α- and β-Antithrombin against Vascular Endothelial Cell Damage Induced by Histone in Vitro
by: Toshiaki Iba, et al.
Published: (2017-06-01) -
The glycocalyx: a novel diagnostic and therapeutic target in sepsis
by: Ryo Uchimido, et al.
Published: (2019-01-01) -
Glycocalyx–Sodium Interaction in Vascular Endothelium
by: Lawrence Fred Sembajwe, et al.
Published: (2023-06-01) -
Endothelial cell activation and glycocalyx shedding - potential as biomarkers in patients with lupus nephritis
by: Susan Yung, et al.
Published: (2023-10-01) -
Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis
by: Jiayun Ying, et al.
Published: (2023-08-01)